The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Viagenpumatucel-L (HS-110) plus nivolumab in patients with advanced non-small cell lung cancer (NSCLC).
 
Daniel Morgensztern
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; Heat Biologics
Research Funding - AstraZeneca (Inst); Baxter (Inst); Celgene (Inst); Clovis Oncology (Inst); Heat Biologics (Inst); Incyte (Inst); Merck (Inst); Newlink Genetics (Inst); Stem CentRx (Inst)
 
Lyudmila Bazhenova
Stock and Other Ownership Interests - Epic Sciences
Consulting or Advisory Role - AstraZeneca; Boston Biomedical; Genentech/Roche; Lilly; Loxo; Pfizer; Takeda
Research Funding - BeyondSpring Pharmaceuticals
 
Saiama Naheed Waqar
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Checkpoint Therapeutics (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Hengrui Therapeutics (Inst); Ignyta (Inst); Lilly (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Spectrum Pharmaceuticals (Inst); Stem CentRx (Inst); Synermore biologics (Inst); Vertex (Inst); Xcovery (Inst)
 
Lori McDermott
Employment - Heat Biologics; Peregrine Pharmaceuticals
Stock and Other Ownership Interests - Heat Biologics; Peregrine Pharmaceuticals
 
Jeff Hutchins
Employment - Heat Biologics; Peregrine Pharmaceuticals
Leadership - Heat Biologics
Stock and Other Ownership Interests - Heat Biologics; Peregrine Pharmaceuticals
 
Wael A. Harb
No Relationships to Disclose
 
Vamsidhar Velcheti
Honoraria - Bristol-Myers Squibb; Foundation Medicine; Genentech/Roche; Merck; Novartis
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Celgene; Clovis Oncology; Foundation Medicine; Genentech; Genoptix; Merck; Takeda
Research Funding - Alkermes (Inst); Altor BioScience (Inst); Atreca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech (Inst); Genoptix (Inst); Heat Biologics (Inst); Leap Therapeutics (Inst); Merck (Inst); NantWorks (Inst); OncoPlex Diagnostics (Inst); Trovagene (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Eisai; Foundation Medicine; Merck
 
Roger B. Cohen
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Cerulean Pharma; Heat Biologics; Kolltan Pharmaceuticals; Pfizer; Takeda; Zymeworks
Research Funding - Celldex (Inst); Cleave Biosciences (Inst); Heat Biologics (Inst); Macrogenics (Inst); Merck (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Cerulean Pharma; Heat Biologics; Kolltan Pharmaceuticals; Pfizer; Takeda; Zymeworks